ESMA LIBRARY
The ESMA Library contains all ESMA documents. Please use the search and filter options to find specific documents.
32
REFINE YOUR SEARCH
Sections
- (-) Remove COVID-19 filter COVID-19
- (-) Remove Innovation and Products filter Innovation and Products
- Corporate Disclosure (191) Apply Corporate Disclosure filter
- CESR Archive (98) Apply CESR Archive filter
- Board of Supervisors (81) Apply Board of Supervisors filter
- IAS Regulation (74) Apply IAS Regulation filter
- Post Trading (60) Apply Post Trading filter
- Securities and Markets Stakeholder Group (46) Apply Securities and Markets Stakeholder Group filter
- MiFID - Secondary Markets (45) Apply MiFID - Secondary Markets filter
- Management Board (38) Apply Management Board filter
- Fund Management (33) Apply Fund Management filter
- IFRS Supervisory Convergence (32) Apply IFRS Supervisory Convergence filter
- Brexit (30) Apply Brexit filter
- Corporate Information (25) Apply Corporate Information filter
- Joint Committee (24) Apply Joint Committee filter
- MiFID - Investor Protection (23) Apply MiFID - Investor Protection filter
- Credit Rating Agencies (19) Apply Credit Rating Agencies filter
- Press Releases (18) Apply Press Releases filter
- Audit (16) Apply Audit filter
- Supervisory convergence (14) Apply Supervisory convergence filter
- Market Integrity (11) Apply Market Integrity filter
- Prospectus (10) Apply Prospectus filter
- Corporate Finance (8) Apply Corporate Finance filter
- Benchmarks (7) Apply Benchmarks filter
- MiFID II: Transparency Calculations and DVC (7) Apply MiFID II: Transparency Calculations and DVC filter
- Securities Financing Transactions (7) Apply Securities Financing Transactions filter
- Transparency (7) Apply Transparency filter
- Corporate Governance (6) Apply Corporate Governance filter
- Trade Repositories (6) Apply Trade Repositories filter
- Market Abuse (5) Apply Market Abuse filter
- Securitisation (5) Apply Securitisation filter
- Short Selling (5) Apply Short Selling filter
- Warnings and publications for investors (5) Apply Warnings and publications for investors filter
- Risk Analysis & Economics - Markets Infrastructure Investors (4) Apply Risk Analysis & Economics - Markets Infrastructure Investors filter
- Speeches (4) Apply Speeches filter
- Sustainable finance (4) Apply Sustainable finance filter
- CCP Directorate (2) Apply CCP Directorate filter
- European Single Electronic Format (2) Apply European Single Electronic Format filter
- Guidelines and Technical standards (2) Apply Guidelines and Technical standards filter
- International cooperation (2) Apply International cooperation filter
- Trading (2) Apply Trading filter
Type of document
- (-) Remove Statement filter Statement
- (-) Remove Letter filter Letter
- (-) Remove Q&A filter Q&A
- Reference (21) Apply Reference filter
- Speech (17) Apply Speech filter
- Opinion (14) Apply Opinion filter
- Press Release (12) Apply Press Release filter
- Report (8) Apply Report filter
- Decision (5) Apply Decision filter
- Final Report (5) Apply Final Report filter
- Consultation Paper (3) Apply Consultation Paper filter
- Technical Advice (2) Apply Technical Advice filter
Your filters Reset all filters
| Date | Ref. | Title | Section | Type | Download | Info | Summary | Related Documents | Translated versions |
|---|---|---|---|---|---|---|---|---|---|
| 25/03/2020 | ESMA32-63-951 | Accounting implications of the COVID-19 outbreak on the calculation of expected credit losses in accordance with IFRS 9 | Corporate Disclosure, COVID-19 | Statement | PDF 135.91 KB |
||||
| 09/04/2020 | ESMA34-45-896 | Actions to mitigate the impact of COVID-19 on the deadlines for the publication of periodic reports by fund managers | COVID-19, Fund Management | Statement | PDF 113.03 KB |
||||
| 09/04/2020 | ESMA80-187-546 | Actions to mitigate the impact of COVID-19 on the EU financial markets regarding the timeliness of fulfilling external audit requirements for interest rate benchmarks under the Benchmarks Regulation | Benchmarks, COVID-19 | Statement | PDF 89.31 KB |
||||
| 31/03/2020 | ESMA35-36-1919 | Clarification of issues related to the publication of reports by execution venues and firms as required under RTS 27 and 28 | COVID-19, MiFID - Investor Protection | Statement | PDF 89.84 KB |
||||
| 07/03/2017 | ESMA50-1623096732-432x | Closing remarks Financial Innovation Day | Innovation and Products | Statement | PDF 152.27 KB |
||||
| 29/06/2020 | ESMA50-164-3475 | Coverletter- ESMA response to EC consultation on a new Digital Finance Strategy for Europe | Innovation and Products | Letter | PDF 87.97 KB |
||||
| 26/03/2020 | ESMA80-191-995 | COVID-19 Public Statement | COVID-19, Securities Financing Transactions | Statement | PDF 113.93 KB |
||||
| 13/11/2017 | ESMA50-157-828 | ESMA alerts firms involved in Initial Coin Offerings (ICOs) to the need to meet relevant regulatory requirements | Innovation and Products, Warnings and publications for investors | Statement | PDF 330.73 KB |
||||
| 13/11/2017 | ESMA50-157-829 | ESMA alerts investors to the high risks of Initial Coin Offerings (ICOs) | Innovation and Products, Warnings and publications for investors | Statement | PDF 444.01 KB |
||||
| 23/05/2018 | ESMA71-99-979 | ESMA appoints new chair to its Committee of Economic and Markets’ Analysis | Innovation and Products, Risk Analysis & Economics - Markets Infrastructure Investors | Statement | PDF 209.05 KB |
||||
| 29/09/2017 | ESMA71-99-602 | ESMA appoints new chairs to Standing Committees | Board of Supervisors, Corporate Disclosure, Corporate Finance, Corporate Information, Innovation and Products, Market Integrity, MiFID - Secondary Markets, Post Trading | Statement | PDF 143.69 KB |
||||
| 09/04/2020 | ESMA70-155-9817 | ESMA postpones the publication dates of the annual transparency calculations for non-equity instruments and for the quarterly systematic internaliser data for non-equity instruments other than bonds | COVID-19, MiFID - Secondary Markets, MiFID II: Transparency Calculations and DVC | Statement | PDF 94.58 KB |
||||
| 20/03/2020 | ESMA35-43-2348 | ESMA Statement on COVID-19 telephone recording | COVID-19, MiFID - Investor Protection | Statement | PDF 114.12 KB |
||||
| 11/03/2020 | ESMA71-99-1290 | ESMA Statement on Markets and COVID-19 | Board of Supervisors, COVID-19 | Statement | PDF 87.99 KB |
||||
| 14/05/2020 | ESMA50-158-2232 | ESMA supports ESRB actions to address COVID-related systemic vulnerabilities | COVID-19, Fund Management | Statement | PDF 81.33 KB |
||||
| 20/05/2020 | ESMA32-63-972 | Implications of the COVID-19 outbreak on the half-yearly financial reports | Corporate Disclosure, COVID-19 | Statement | PDF 111.97 KB |
||||
| 10/04/2019 | ESMA 50-164-2193 | Letter to EC- FinTech action plan- ICT cybersecurity and outsourcing | Innovation and Products | Letter | PDF 58.38 KB |
||||
| 20/08/2019 | ESMA50-164-2554 | Letter to EC- Joint EBA ESMA response on crypto-assets | Innovation and Products | Letter | PDF 93.63 KB |
||||
| 11/05/2020 | ESMA32-61-403 | Letter to EFRAG on IASB Exposure Draft COVID-19 Related Rent Concessions | Corporate Disclosure, COVID-19 | Letter | PDF 127.34 KB |
||||
| 11/05/2020 | ESMA32-61-402 | Letter to IASB Exposure Draft COVID-19 Related Rent Concessions | Corporate Disclosure, COVID-19 | Letter | PDF 122.4 KB |